Abstract
许华斌,汪兴太,庄辉.美国狂犬病的预防策略与挑战[J].Chinese journal of Epidemiology,2009,30(10):1081-1083
美国狂犬病的预防策略与挑战
Rabies prevention strategies and challenges in the United States
Received:February 28, 2009  
DOI:
KeyWord: 狂犬病  预防策略  疫苗接种
English Key Word: Rabies  Prevention strategies  Vaccination
FundProject:美国中华医学基金会(CMB)
Author NameAffiliationE-mail
XU Hua-bin Department of Laborasory Medicine the Second People's Hospital of Liuan City, Liuan 237008, China  
WANG Xing-tai 美国马萨诸塞州立实验研究所  
ZHUANG Hui 北京大学医学部病原生物学系 zhuangbmu@126.com 
Hits: 2160
Download times: 1101
Abstract:
      狂犬病是由狂犬病毒所导致的人畜共患疾病.欧美国家的狂犬病流行毒株包括犬株、蝙蝠株和浣熊株等~([1]).美国在第二次世界大战后,通过对宠物犬疫苗接种和野犬等的有效控制,人畜狂犬病的病例数显著下降.1946年,美国报告8384只病犬狂犬病和33例人狂犬病确诊病例.
English Abstract:
      Objective To investigate the efficacy and safety of ezctimibe on uncontrolled LDL-C when added to ongoing statin therapy in patients with coronary heart diseases (CHD) and diabetes mellitus (DM). Methods 61 patients with LDL-C level exceeding target goal (<2.07 mmol/L) after 12 weeks' treatment with statins, received ezetimibe in addition to their ongoing statin therapy for 8 weeks. Lipid parameters, alanine aminotransferase(ALT), aspartic aminotransferase(AST) and ereatine kinase(CK) were compared before and after the adding of ezetimibe. Results LDL-C before and after the adding of ezetimibe was (2.74±0.43) mmol/L and (2.19±0.32) mmol/L, respectively (P=0.03) in 61 patients. Ezetimibe added to statin therapy significantly reduced the LDL-C level and TC level by additional 20.1% and 19.1%, respectively (P<0.05). 74%(45/61) patients treated with ezetimibe added to statin reached their target LDL-C goal. No change of TG and HDL-C was observed and no change of AST, ALT and CK was found either. Conclusion Ezetimibe added to statin therapy lowered LDL-C level further and improved the goal attainment in patients with CHD and DM.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close